ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INM InMed Pharmaceuticals Inc

0.2351
-0.0169 (-6.71%)
Last Updated: 12:50:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 397,306
Bid Price 0.235
Ask Price 0.24
News -
Day High 0.25

Low
0.227503

52 Week Range

High
2.08

Day Low 0.227503
Company Name Stock Ticker Symbol Market Type
InMed Pharmaceuticals Inc INM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0169 -6.71% 0.2351 12:50:17
Open Price Low Price High Price Close Price Prev Close
0.245 0.227503 0.25 0.252
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
731 397,306 $ 0.2394845 $ 95,149 - 0.227503 - 2.08
Last Trade Time Type Quantity Stock Price Currency
12:50:45 100 $ 0.2351 USD

InMed Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.39M 6.06M - 4.14M -7.95M -1.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

InMed Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No INM Message Board. Create One! See More Posts on INM Message Board See More Message Board Posts

Historical INM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2910.3370.2275030.2943302886,887-0.0559-19.21%
1 Month0.350.45550.2275030.3239629786,314-0.1149-32.83%
3 Months0.35370.47180.2275030.3413458391,494-0.1186-33.53%
6 Months0.6550.7290.2275030.3766128306,319-0.4199-64.11%
1 Year1.162.080.2275030.8361286604,535-0.9249-79.73%
3 Years2.9519.500.2275032.84758,772-2.71-92.03%
5 Years3.7019.500.2275032.89684,395-3.46-93.65%

InMed Pharmaceuticals Description

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Your Recent History

Delayed Upgrade Clock